""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"publication_reference_url"
"subject"	""	""	""	"cell_subset"	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"url"
"role"	""	""	""	"tissue"	"background"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"background"	"background"	"background"	"background"	"background"	"background"	"observed"	"background"	"background"	"reference"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (cell subset)"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"target pathogen"	"vaccine year"	"exposure material"	""	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"publication url"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"peripheral blood mononuclear cell"	"T cell"	"Cell type frequency"	"up"	"none"	"8"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"8d-0d"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"peripheral blood mononuclear cell"	"T cell"	"Cell type frequency"	"up"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"14d-0d"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"peripheral blood mononuclear cell"	"T cell"	"Cell type frequency"	"up"	"none"	"28"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"28d-0d"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"peripheral blood mononuclear cell"	"T cell"	"Cell type frequency"	"down"	"none"	"28"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"28d-8d"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"peripheral blood mononuclear cell"	"CD38+HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)"	"Cell type frequency"	"up"	"none"	"8"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"14d-0d"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"peripheral blood mononuclear cell"	"CD38+HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)"	"Cell type frequency"	"up"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"14d-0d"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"mitotic cell cycle in stimulated CD4 T cells (M4.5)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"enriched for promoter motif NATCACGTGAY (putative SREBF1 targets) (M178)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"enriched in B cells (V) (M47.4)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"DNA repair (M76)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"mismatch repair (II) (M22.1)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"cell cycle (III) (M103)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"mitotic cell cycle - DNA replication (M4.4)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"mitotic cell division (M6)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"regulation of antigen presentation and immune response (M5.0)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"TBA (M177.0)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"E2F transcription factor network (M8)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"cell division (stimulated CD4+ T cells) (M46)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"C-MYC transcriptional network (M4.12)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"cell division in stimulated CD4 T cells (M4.6)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"mismatch repair (I) (M22.0)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"PLK1 signaling events (M4.2)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"enriched in B cells (III) (M47.2)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"cytoskeleton/actin (SRF transcription targets) (M145.0)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"cell cycle (I) (M4.1)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"chaperonin mediated protein folding (I) (M204.0)"	"Cell type frequency"	"negative"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"TBA (M184.1)"	"Cell type frequency"	"positive"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"TBA (M184.0)"	"Cell type frequency"	"positive"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"TBA (M98.0)"	"Cell type frequency"	"positive"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"TBA (M197)"	"Cell type frequency"	"positive"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
""	"20181102-hipciof_ctf_27764254"	"2018.11.02"	"hipciof_ctf"	"blood"	"TBA (M170),"	"Cell type frequency"	"positive"	"none"	"14"	"Days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"associated with expension of VZV specific T cells (0d to peak)"	"time of vaccination (first dose)"	"seniors (50-75)"	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27764254"
